Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Basset

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
La Revue De Medecine Interne|January 1, 1981
[Oltipraz in one-day treatment of Schistosoma haematobium bilharziasis (pharmacokinetic data, therapeutic effects)]R Piéron, B Lesobre, Y Mafart, et al.
International Journal of Cancer|July 2, 1999
Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomasM P Chenard, Y Lutz, A Mechine-Neuville, et al.
Biochimica Et Biophysica Acta|May 30, 1975
Haemoglobin Saki alpha 2 beta 2 14 Leu-Pro(a11) structure and functionY Beuzard, P Basset, F Braconnier, et al.
The Journal of Biological Chemistry|October 27, 1995
Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinomaC H Régnier, C Tomasetto, C Moog-Lutz, et al.
Critical Reviews in Oncology/Hematology|May 1, 1997
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progressionP Basset, J P Bellocq, O Lefebvre, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|October 6, 1998
[Extracellular proteases of stromal origin: contribution to tumor progression and therapeutic perspectives]M C Rio, R Masson, M P Chenard, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 1, 1997
Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implicationsP Basset, A Okada, M P Chenard, et al.
The Biochemical Journal|May 1, 1996
Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertasesM Santavicca, A Noel, H Angliker, et al.
The Journal of Hospital Infection|July 25, 2016
New genotyping method discovers sustained nosocomial Pseudomonas aeruginosa outbreak in an intensive care burn unitF Tissot, D S Blanc, P Basset, et al.
The Journal of Experimental Medicine|March 2, 1999
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivoU Schönbeck, F Mach, G K Sukhova, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
La Revue De Medecine Interne|January 1, 1981
[Oltipraz in one-day treatment of Schistosoma haematobium bilharziasis (pharmacokinetic data, therapeutic effects)]R Piéron, B Lesobre, Y Mafart, et al.
International Journal of Cancer|July 2, 1999
Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomasM P Chenard, Y Lutz, A Mechine-Neuville, et al.
Biochimica Et Biophysica Acta|May 30, 1975
Haemoglobin Saki alpha 2 beta 2 14 Leu-Pro(a11) structure and functionY Beuzard, P Basset, F Braconnier, et al.
The Journal of Biological Chemistry|October 27, 1995
Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinomaC H Régnier, C Tomasetto, C Moog-Lutz, et al.
Critical Reviews in Oncology/Hematology|May 1, 1997
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progressionP Basset, J P Bellocq, O Lefebvre, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|October 6, 1998
[Extracellular proteases of stromal origin: contribution to tumor progression and therapeutic perspectives]M C Rio, R Masson, M P Chenard, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 1, 1997
Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implicationsP Basset, A Okada, M P Chenard, et al.
The Biochemical Journal|May 1, 1996
Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertasesM Santavicca, A Noel, H Angliker, et al.
The Journal of Hospital Infection|July 25, 2016
New genotyping method discovers sustained nosocomial Pseudomonas aeruginosa outbreak in an intensive care burn unitF Tissot, D S Blanc, P Basset, et al.
The Journal of Experimental Medicine|March 2, 1999
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivoU Schönbeck, F Mach, G K Sukhova, et al.
Pageof 11